[NS398 induced apoptosis in pancreatic carcinoma cell strain BxPC-3 through a COX-2-in dependent pathway]

Dong-sheng Huang1, Xiao Xu, Shu-sen Zheng

  • 1Department of Hepatobiliary Pancreatic Surgery, the First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou 310003, China. dshuang@mail.hz.zj.cn

Abstract

Insights

The selective cyclooxygenase-2 (COX-2) inhibitor NS398 demonstrated antiproliferative and proapoptotic effects on human pancreatic cancer cells. This action was linked to Caspase-3 activation, not COX-2 inhibition.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Context:

  • Pancreatic cancer remains a significant health challenge with limited effective treatments.
  • Cyclooxygenase-2 (COX-2) is implicated in tumor growth and inflammation.
  • Targeting specific molecular pathways is crucial for developing novel cancer therapies.

Purpose:

  • To investigate the impact of the selective COX-2 inhibitor NS398 on human pancreatic tumor BxPC-3 cell line growth.
  • To elucidate the underlying mechanisms of NS398's action, including its effect on apoptosis and key protein expressions.

Summary:

  • NS398 significantly reduced BxPC-3 cell viability and induced apoptosis.
  • High concentrations of NS398 led to increased Caspase-3 protein expression and activation.
  • The observed antiproliferative and proapoptotic effects were independent of COX-2 but correlated with Caspase-3 activation.

Impact:

  • This study reveals a novel therapeutic potential for NS398 in pancreatic cancer treatment.
  • The findings highlight the critical role of Caspase-3 activation in mediating NS398's anti-cancer effects.
  • Understanding these mechanisms could pave the way for developing more targeted pancreatic cancer therapies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.